Title: Hospital Medicine- Cardiology: Valvular Heart Disease; Sudden Cardiac Death, Bradycardia and Atrioventricular Block; Diastolic Heart Failure and Hypertrophic Cardiomyopathy.
Course ID: HMca
Faculty:
Nicholas J. Ruggiero II, M.D., F.A.C.P., F.A.C.C., F.S.C.A.I., F.S.V.M., F.C.P.P
Alyson N. Owen, M.D.
Assistant Professor of Medicine, Division of Cardiology, Sidney Kimmel Medical College, Thomas Jefferson University; Director of Quality Assurance, Echocardiography Laboratory, Thomas Jefferson University Hospital, Philadelphia, PA
Original Release Date: July 1, 2021 Expiration Date: July 1, 2024
TOPIC 1:Valvular Heart Disease.
Upon completion of this session, the participant should be able to: GL, EBM, COMP
- Indicate when to order echocardiography for heart murmurs.
- Recognize the appropriate interval of repeat echocardiography imaging.
- Determine the timing of intervention for severe valvular heart disease as per the ACC/AHA Guidelines.
- Integrate the indications, strengths and weaknesses of Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter mitral valve repair.
- Discriminate the current and past indications for endocarditis prophylaxis as per the ACC/AHA Guidelines.
TOPIC 2:Sudden Cardiac Death, Bradycardia and Atrioventricular Block.
Upon completion of this session, the participant should be able to: EBM, GL, COMP
- Determine which patients need additional evaluation and treatment of ventricular arrhythmias.
- Assess which patients need additional evaluation and treatment of cardiac conduction abnormalities as per ACC/AHA/HRS Guidelines.
- Recognize indications for permanent pacemakers.
TOPIC 3:Diastolic Heart Failure and Hypertrophic Cardiomyopathy.
Upon completion of this session, the participant should be able to: EBM, COMP
- Describe the prevalence and pathophysiology of diastolic heart failure.
- Identify effective treatment strategies for diastolic heart failure while considering Clinical Trials such as OPTIMIZE-HF, TOPCAT, PARAMOUNT, etc.
- Assess prognosis in patients with hypertrophic cardiomyopathy.
- Apply appropriate treatment strategies in patients with hypertrophic cardiomyopathy.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.